Tirzepatide outscores Semglutide for weight loss in head to head comparison Dr Kartikeya Kohli11 July 2023 10:00 AM ISTObesity treatment widely ranges from lifestyle changes to many drugs. Obesity is now recognized as a disease and treatments that induce short-term...
Wegovy maker Novo Nordisk sues Florida pharmacies over copycat drugs Ruchika Sharma10 July 2023 1:30 PM ISTNovo Nordisk said that the pharmacies are selling new drugs without FDA approval and claiming to compete with Novo Nordisk's approved drugs, violating...
Survodutide leads to striking weight loss in people who are overweight or obese: Phase II trial Medha Baranwal6 July 2023 11:30 AM ISTUSA: A Phase II study has shown superior efficacy of survodutide versus placebo in people with obesity or overweight without type 2 diabetes following...
Withhold GLP-1 receptor agonists before elective surgery suggests ASA Dr. Kamal Kant Kohli2 July 2023 8:00 PM ISTUSA: The American Society of Anesthesiologists (ASA) suggests withholding glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery to...
Type 2 diabetes: Combo of semaglutide and cagrilintide reduces blood sugar and leads to weight loss Medha Baranwal1 July 2023 11:00 AM ISTUSA: Co-administration of once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg (CagriSema) improves glycemic control and leads to...
Daily oral orforglipron leads to significant weight loss in obese/overweight people: NEJM Medha Baranwal30 Jun 2023 8:00 PM ISTUSA: Daily oral orforglipron led to weight loss in adults with obesity, or with overweight plus at least one weight-related coexisting condition, and...
Medical Bulletin 28/June/2023 Isra Zaman28 Jun 2023 3:05 PM ISTHere are the top medical news for the day: A novel generic treatment for various forms of cancerResearchers led by Katsunori Tanaka at the RIKEN...
High doses of oral semaglutide improve blood sugar control and promote weight loss Isra Zaman28 Jun 2023 9:15 AM ISTDiabetes is a progressive disease that affects one's ability to control blood sugar levels. For many patients, the condition becomes more severe over...
Pfizer scraps once-a-day experimental obesity pill over liver safety concerns Ruchika Sharma27 Jun 2023 2:30 PM ISTNew York: Pfizer Inc said it is scrapping its once-a-day experimental obesity pill because of concerns about liver safety, but will continue...
SADI or SASI bariatric surgery, which is better for long-term weight loss? Medha Baranwal12 Jun 2023 8:00 PM ISTAustralia: A systematic review has shown that single anastomosis duodenal-ileal (SADI) bypass and single anastomosis sleeve-ileal (SASI) bypass can...
Semaglutide improves cardiovascular health in users in addition to causing weight loss: Study Medha Baranwal31 May 2023 11:15 AM ISTUSA: Semaglutide use in obese/overweight patients may decrease the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in addition to...
Semaglutide use tied to significant weight loss in multicentre, one-year real-world study Dr. Kamal Kant Kohli23 May 2023 11:00 AM ISTUSA: Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is shown to be effective in a multicentre, 1-year-long real-world study...
